| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/16/2007 | EP1784399A2 Pyrimidine derivatives |
| 05/16/2007 | EP1784397A1 5-(1,1'-biphenyl)-4-yl-5-(4-(4-aminoacylphenyl)-piperazin)-1-yl-pyrimidine-2,4,6-trione derivatives, as inhibitors of zinc metallondopeptidases, their preparation and use |
| 05/16/2007 | EP1784221A2 Methods for the treatment and prevention of infection using anti-selectin agents |
| 05/16/2007 | EP1784200A1 Method and composition for modulation of systemic inflammatory responses syndrome (sirs) |
| 05/16/2007 | EP1372700B1 Stable aqueous solutions of granulocyte macrophage colony-stimulating factor |
| 05/16/2007 | EP1306373B1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 05/16/2007 | EP1265900B1 1,5-disubstituted-3,4-dihydro-1h-pyrimido 4,5-d|pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 05/16/2007 | EP1115405B1 Use of tnf-alpha inhibitors for treating nerve root injury |
| 05/16/2007 | DE202007002146U1 Neue Kräuterzusammensetzung New herbal composition |
| 05/16/2007 | CN1964985A 3-beta-D-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and uses thereof |
| 05/16/2007 | CN1962698A Use of argyi leaf polysaccharide extract |
| 05/16/2007 | CN1962692A Staphylococcus aureus enterotoxin E and its preparation and uses |
| 05/16/2007 | CN1962691A Thymus tetrapeptide active isomer and its preparation method and medicinal uses |
| 05/16/2007 | CN1962641A Metalloproteinase inhibitors |
| 05/16/2007 | CN1961906A Diterpene extract of Siegesbeckia, its preparation process and use thereof in phamacy |
| 05/16/2007 | CN1961866A Nano-emulsion drug of triperygium wilfordii polycoride and preparation method thereof |
| 05/16/2007 | CN1316030C New usage of strain of lactobacillus for curing irritability |
| 05/16/2007 | CN1315867C 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 05/16/2007 | CN1315840C Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives used as drug for treating pain |
| 05/16/2007 | CN1315835C Polycyclic guanine phosphodiesterase v inhibitors |
| 05/16/2007 | CN1315833C Azaindole kinase inhibitors |
| 05/16/2007 | CN1315822C Quinoline derivatives having VEGF inhibiting activity |
| 05/16/2007 | CN1315806C Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 05/16/2007 | CN1315535C Adjuvant for improving hepatitis B vaccine immune effect and preparing method thereof |
| 05/16/2007 | CN1315530C Method of preparing system for controlled release of medication in protein category |
| 05/15/2007 | USRE39634 treatment of neuropathic pain; elevate levels of anandamide or other endogenous cannabinoids to increase the nociceptive threshold |
| 05/15/2007 | US7217826 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate |
| 05/15/2007 | US7217732 Cannabinoid receptor agonists |
| 05/15/2007 | US7217729 4,6-Dimethyl-3-{[3'-(N,N-dimethylaminomethyl)-4-hydroxy-4'-(3''-methoxyphenyl)-cyclohexylamino]-methyl}-1H-indole 2-carboxylic acid ethyl ester or other derivatives of substituted indoles; for treatment or prevention of neurodegenerative diseases, psychological disorders, AIDS, inflammation or allergies |
| 05/15/2007 | US7217718 Administering an immunosuppressant; therapy for autoimmune disease |
| 05/15/2007 | US7217701 Intracellular calcium concentration increase inhibitors |
| 05/15/2007 | US7217539 Cell death inducers for mast cells |
| 05/15/2007 | US7217534 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 05/15/2007 | CA2392973C Benzoimidazole derivatives useful as antiproliferative agents |
| 05/15/2007 | CA2366829C Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives |
| 05/15/2007 | CA2366186C Retinoid antagonists and use thereof |
| 05/15/2007 | CA2249736C Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection |
| 05/15/2007 | CA2176948C Chaperonin 10 |
| 05/15/2007 | CA2065414C Treatment of autoimmune disease |
| 05/15/2007 | CA2011633C Intercellular adhesion molecule - 2 and its binding ligands |
| 05/10/2007 | WO2007053658A1 Pirfenidone/toll-like receptor (tlr) agonist compositions and methods for using them to stimulate production of granulocyte colonizing stimulating factor (g-csf) |
| 05/10/2007 | WO2007052643A1 Lactic acid bacterium having immunoregulatory activity derived from moromi for wine fermentation |
| 05/10/2007 | WO2007052641A1 Intestinal immunity activator |
| 05/10/2007 | WO2007052398A1 Method of screening compound useful in treating allergic disease |
| 05/10/2007 | WO2007051476A1 Use of a liquid allergy vaccine formulation for oromucosal administration |
| 05/10/2007 | WO2007014169A3 Anti-cd26 antibodies and methods of use thereof |
| 05/10/2007 | WO2007007173A3 Human anti-madcam antibodies |
| 05/10/2007 | WO2007006171A8 A traditional chinese medicine composition, the preparation and quality controlling method thereof |
| 05/10/2007 | WO2007003904A3 Prophylactic and immunomodulatory compositions and uses |
| 05/10/2007 | WO2007002096A3 Methods and compositions for targeting ifnar2 |
| 05/10/2007 | US20070106062 Attenuated vif DNA immunization cassettes for genetic vaccines |
| 05/10/2007 | US20070105949 Intermediates for the preparation of lipoxin A4 analogs |
| 05/10/2007 | US20070105936 new crystals forms of Sodium trans-4-[1-[2,5-dichloro-4-[(1-methyl-1H-3-indolylcarbonyl)amino]phenylacetyl]-(4S)-methoxy(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylate pentahydrate; VLA-4 (very late antigen-4) inhibitor; therapeutic drug for disorders caused by cell adhesion; water soluble, stability |
| 05/10/2007 | US20070105933 Amino alcohol compounds |
| 05/10/2007 | US20070105908 Thiazolimine compound and oxazolimine compound |
| 05/10/2007 | US20070105886 Steroidal compounds for inhibiting steroid sulphatase |
| 05/10/2007 | US20070105860 Biphenylcarboxylic Amide Derivatives as p38 Kinase Inhibitors |
| 05/10/2007 | US20070105859 4-Phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (mek) inhibitors |
| 05/10/2007 | US20070105127 DNA libraries comprising vector constructs coding glycosylation enzymes and organelle targeting signal sequences for use in modifying exogenously expressed polypeptides |
| 05/10/2007 | US20070104776 Drug having regulatory cell ligand contained in liposome |
| 05/10/2007 | US20070104733 Tissue targeted antigenic activation of the immune response to cancers |
| 05/10/2007 | CA2779041A1 Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties |
| 05/10/2007 | CA2628226A1 Use of a liquid allergy vaccine formulation for oromucosal administration |
| 05/10/2007 | CA2627423A1 Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (hdac) inhibitors |
| 05/09/2007 | EP1783227A1 Humanized anti-CCR2 antibodies and methods of use therefor |
| 05/09/2007 | EP1783141A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/09/2007 | EP1782826A1 PQS and c-diGMP and its conjugates as adjuvants and their uses in pharmaceutical compositions |
| 05/09/2007 | EP1782824A2 Diaminooxidase-containing pharmaceutical preparations |
| 05/09/2007 | EP1782823A2 IL-21 peptides and nucleic acids |
| 05/09/2007 | EP1782804A1 Medicinal composition as immunosuppressant |
| 05/09/2007 | EP1782801A1 Eyewash liquid for dry eye therapy |
| 05/09/2007 | EP1782800A2 JAK/STAT pathway inhibitors and the uses thereof |
| 05/09/2007 | EP1781689A1 Conjugates and therapeutic uses thereof |
| 05/09/2007 | EP1781685A1 Therapeutic and diagnostic agents |
| 05/09/2007 | EP1781654A1 Pyrrolo-pyridine kinase modulators |
| 05/09/2007 | EP1781640A1 2,4-di(aminophenyl)pyrimidine derivatives as plk inhibitors |
| 05/09/2007 | EP1781638A2 Imidazolo-related compounds, compositions and methods for their use |
| 05/09/2007 | EP1781619A1 Sigma receptor inhibitors |
| 05/09/2007 | EP1781618A1 Sigma receptor inhibitors |
| 05/09/2007 | EP1781606A2 Azetidine derivatives as ccr-3 receptor antagonists |
| 05/09/2007 | EP1781595A1 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity |
| 05/09/2007 | EP1781378A2 Method of treating sjögren's syndrome |
| 05/09/2007 | EP1781290A2 Anti-inflammatory agents |
| 05/09/2007 | EP1781269A2 IgE-RETARGETING, FUNCTION-ALTERING MOLECULES (ERFAM) FOR TREATMENT OF ALLERGIC DISEASES |
| 05/09/2007 | EP1781267A2 Methods and reagents for the treatment of immunoinflammatory disorders |
| 05/09/2007 | EP1781235A1 Anti-hypersensitive inflammation and anti-allergy activities of zingiber zerumbet (l.) smith |
| 05/09/2007 | EP1731530A9 A kind of fusion protein, gene encoding it, expression method and use thereof |
| 05/09/2007 | EP1654229B1 Piperidine derivatives as ccr5 receptor modulators |
| 05/09/2007 | EP1501796B1 3-(pyridinyl-amino)-1h-indole-2-carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
| 05/09/2007 | EP1408941B1 Use of a pharmaceutical composition comprising two quaternary ammonium compounds and an organometallic one in the treatment of viral and fungal infections and diseases |
| 05/09/2007 | EP1319020B1 VARIANTS OF THE MAJOR ALLERGEN Par j 2 OF Paritaria judaica |
| 05/09/2007 | EP1254169B1 Methods relating to modulation of th2 cell subset activity by modulation of xbp-1 activity |
| 05/09/2007 | EP1191931B1 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 |
| 05/09/2007 | EP1137792B1 A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 05/09/2007 | CN1960764A Combinations comprising a S1P receptor agonist and a JAK3 kinase inhibitor |
| 05/09/2007 | CN1960758A Remedy or preventive for arthritis |
| 05/09/2007 | CN1960751A Vaccine compositions obtained from streptomyces |
| 05/09/2007 | CN1958615A Antibody of anti human CD20 from human resources functionally, and application |
| 05/09/2007 | CN1958606A Recombined composite epitope antigen of liver cancer, preparation method, and application of preparing medication for specific immunity treatment of liver cancer |
| 05/09/2007 | CN1958065A Pidotimod capsule, and preparation |